Generic Name
ZiprasidonePacks Price
- Cap 60 mg: 20: 2060.23: 2423.80
- Cap 40 mg: 10: 818.37: 962.79
- Cap 40 mg: 14: 114.57: 1346.56
- Cap 40 mg: 20: 1554.32: 1828.62
- Cap 40 mg: 30: 2258.24: 2656.76
Ziprowin
Therapeutic Group
Psycholeptics (Antipsychotic, Anxiolytic/Hypnotic)Indication Dosage
Ziprasidone is a medication used to treat certain mental health conditions like schizophrenia and bipolar disorder. It helps to balance chemicals in the brain and can reduce symptoms like hallucinations, mood swings, and confusion. Your doctor may prescribe it to help you feel better and manage your condition. Remember to take it as directed and talk to your doctor about any questions or concerns.
Schizophrenia And Other Psychoses:
- Adult: Initially 20 Mg Twice Daily, Max: 80 Mg Twice Daily.
Bipolar Disorder, Acute Manic And Mixed Episodes:
- Adult: Initially40 Mg Twice Daily, Increase To 60-80 Mg Twice Daily On 2nd Day Of Treatment;
- Maintenance: 40-80 Mg Twice Daily
Content
- Cap /Tab 20mg /40mg /60mg /80mg: Ziprasidone 20mg /40mg /60mg /80mg.
Pregnancy
Avoid Unless Potential Benefit Outweighs Risk
Stability
- Benzyl Iso Thiazolyl Piperazine
Contra Indications
- Qt-interval Prolongation, Recent Myocardial Infarction, Uncompensated Heart Failure, Cardiac Arrhythmias, Drugs That Prolong Qt Interval.
Precautions
- Qt-interval Prolongation, Recent Myocardial Infarction, Uncompensated Heart Failure, Cardiac Arrhythmias, Drugs That Prolong Qt Interval.
Lactation
- Contraindicated, Avoid
Side Effects
- Acute Dystonic Reactions Such As Facial And Skeletal Muscle Spasms And Oculogyric Crises
- Leucopenia
- Hyperprolactinaemia
- Acute Dyskinesias
- Akathisia
- Parkinsonism
- Drowsiness
- Insomnia
- Agitation
- Tachycardia
- Arrhythmias; Ecg Changes
- Hypotension
- Antieholinergiceffects (e.g. Dry Mouth, Blurred Vision)
- Respiratory Depression
- Rash
- Photosensitivity
- Hypoglycaemia
- Impaired Tem-perature Regulation
- Convulsions
- Male Sexual Dysfunction
- Rarely
- Agranulocytosis
- Tardive Dyskinesia
- Jaundice
- Neuroleptic Malignant Syndrome
- Pigmentary Retinopathy
Author
Shahid Arif